Join now & save up to 80% on medication

JOIN NOW
Select Language:

Join now and save 80% on medication

Register/Login

Glyburide and Hypoglycemia

Share Post:

What is Glyburide ?

Glyburide belongs to the group of second-generation sulfonylureas—a type of medication that is used to treat type 2 diabetes. People with type 2 diabetes has high sugar levels in their blood because their bodies cannot properly store excess sugar. Sulfonylureas were among the first oral medications developed for high blood sugar levels. They are generally well-tolerated and less expensive.

Insulin is an essential hormone that allows the body to turn sugar from food into energy or store it for future use. Glyburide works by stimulating the pancreas to release more insulin into the bloodstream and into the cells to provide energy; eventually lowering the blood sugar level. An important concern regarding the use of anti-hyperglycemic drugs is their ability to cause hypoglycemia (low blood sugar level). Hypoglycemic attacks are dangerous because they can lead to seizures, loss of consciousness, and even death.

Symptoms of Hypoglycemia

  • Sweating
  • Extreme hunger
  • Dizziness
  • Shakiness
  • Rapid heart rate
  • Blurred vision
  • Weakness
  • Headache
  • Unconsciousness

Glyburide and Hypoglycemia

Several studies suggest that glyburide is associated with more hypoglycemic attacks than most sulfonylureas. Additionally, this medication is contraindicated in patients with renal impairment or severe hepatic impairment because of the high risk of hypoglycemia.

Results from other notable studies:

  1. Glyburide can be a therapeutic option for women with gestational diabetes mellitus, but it is currently not approved for such indication.
  2. A meta-analysis of 21 studies revealed that patients receiving glyburide has a 52% higher risk of hypoglycemia than those taking other insulin medications.
  3. When compared with other second-generation sulfonylureas, hypoglycemia occurred twice as often in patients receiving this drug than those taking glipizide.
  4. The higher risk of hypoglycemia in glyburide is not associated with lower glycated hemoglobin values (HbA1c); the average glucose concentration in the plasma that is useful in diagnosing diabetes.
  5. Patients receiving glyburide, except those with gestational diabetes mellitus, may be switched to glimepiride or glipizide.

You can check Glyburide cost at canadianinsulin.com.


Disclaimer: Please note that the contents of this community article are strictly for informational purposes and should not be considered as medical advice. This article, and other community articles, are not written or reviewed for medical validity by Canadian Insulin or its staff. All views and opinions expressed by the contributing authors are not endorsed by Canadian Insulin. Always consult a medical professional for medical advice, diagnosis, and treatment.
Profile image of CDI Staff Writer

Written by CDI Staff WriterOur internal team are experts in many subjects. on April 11, 2022

Related Articles

Cardiovascular Health, Diabetes,
New Data Proving Metformin is Healthy for the Heart in People with Type 2 Diabetes

Type 2 diabetes mellitus (T2DM) affects millions of people worldwide and significantly increases the risk of heart disease. While managing blood sugar levels is crucial, recent research suggests that some…

Read More
Diabetes, Diabetes Supplies,
Pioglitazone: A Promising Ally Against Sepsis in Type 2 Diabetes Patients

Understanding Sepsis and Its Impact on Diabetic PatientsSepsis is a life-threatening condition that arises when the body’s response to infection causes injury to its own tissues and organs. It’s a…

Read More
Cardiovascular Health, Diabetes,
Pioglitazone: Beneficial for Everything Including Heart Failure?

Pioglitazone is a medication that has been used since 1985 to manage type 2 diabetes mellitus (T2DM). As an insulin sensitizer in the thiazolidinedione (TZD) class, it helps control blood…

Read More
Cancer, Diabetes, Type
GLP-1 Receptor Agonists: A Promising Avenue for Reducing Liver Cancer Risk in Type 2 Diabetes Patients

Hepatocellular carcinoma (HCC) stands as one of the most lethal cancers worldwide, with rising incidence rates paralleling the global increase in obesity, type 2 diabetes, and nonalcoholic fatty liver disease…

Read More